SP Group A/S (CPH:SPG)
Denmark
· Delayed Price · Currency is DKK | Market Cap | 4.18B |
| Revenue (ttm) | 2.95B |
| Net Income (ttm) | 265.00M |
| Shares Out | 11.75M |
| EPS (ttm) | 22.13 |
| PE Ratio | 16.06 |
| Forward PE | 12.34 |
| Dividend | 4.00 (1.13%) |
| Ex-Dividend Date | Apr 30, 2026 |
| Volume | 7,569 |
| Average Volume | 8,622 |
| Open | 353.00 |
| Previous Close | 355.50 |
| Day's Range | 353.00 - 362.00 |
| 52-Week Range | 254.50 - 400.00 |
| Beta | 1.21 |
| RSI | 44.60 |
| Earnings Date | Apr 29, 2026 |
About SP Group
SP Group A/S, together with its subsidiaries, manufactures and sells moulded plastic and composite components in Denmark, rest of Europe, the Americas, Asia, the Middle East, Australia, and Africa. The company offers hydrographic printing, electromagnetic shielding, other coatings; solid, foamed, flexible, and light-foam polyurethane products; and ventilation equipment, ergonomic matting, and striping products. It also offers vacuum forming, high-pressure, and twin-sheet thermoformed plastic components for use in refrigerators, freezers, cars, ... [Read more]
Financial Performance
In 2025, SP Group's revenue was 2.95 billion, an increase of 0.90% compared to the previous year's 2.92 billion. Earnings were 265.00 million, an increase of 1.56%.
Financial StatementsNews
SP Group Earnings Call Transcript: Q4 2025
Record Q4 drove modest full-year growth, with strong subcontracting offsetting own product declines. 2026 guidance is ambitious, fueled by the Idé-Pro acquisition and new customer agreements, but risks remain from geopolitical and raw material uncertainties.
SP Group Transcript: M&A Announcement
The acquisition brings advanced prototyping, in-house tool production, and new material capabilities, with expected annual synergies of DKK 20–25 million and significant revenue and EBITDA growth by 2026. Integration leverages existing teams, and immediate cross-selling is underway.
Q3 2025 SP Group A/S Earnings Call Transcript
Q3 2025 SP Group A/S Earnings Call Transcript
SP Group Earnings Call Transcript: Q3 2025
Q3 2025 saw a 3.3% sales decline due to postponed orders and weaker own product sales, but sub-supplier business grew and the order book for Q4 is strong. Full-year guidance is maintained, with major investments in healthcare capacity and a leadership transition planned.
SP Group Earnings Call Transcript: Q2 2025
Record Q1 was followed by a Q2 slowdown, with H1 revenue down 1.2% and margins pressured by postponed orders and lower own product sales. Full-year guidance was revised to flat revenue, with continued investment in medical capacity and increased share buybacks.
SP Group Earnings Call Transcript: Q1 2025
Q1 2025 delivered record revenue and profit, led by strong healthcare growth and robust own brand sales. Investments focused on medical production capacity, while tariff and geopolitical uncertainties remain a risk. Net debt to EBITDA reached a low of 1.3.
SP Group Earnings Call Transcript: Q4 2024
Record 2024 results with 12% revenue growth and strong margin expansion driven by own products. 2025 guidance is more cautious, targeting 3%-10% growth amid industrial uncertainty, with continued focus on organic growth, acquisitions, and sustainability.
SP Group A/S (FRA:1PU2) Q2 2024 Earnings Call Transcript Highlights: Strong Revenue Growth and ...
SP Group A/S (FRA:1PU2) Q2 2024 Earnings Call Transcript Highlights: Strong Revenue Growth and Strategic Expansions
Q2 2024 SP Group A/S Earnings Call Transcript
Q2 2024 SP Group A/S Earnings Call Transcript
SP Group Earnings Call Transcript: Q2 2024
H1 2024 saw robust revenue and profit growth, driven by proprietary products and international sales, with upgraded full-year guidance and a new U.S. factory completed. Sustainability initiatives advanced, and a share buyback program was launched.